Development of point-of-care assessment tools that can simultaneously measure Hb as well as key anemia risk factors (for example, inflammation, iron deficiency, malaria, and hemoglobinopathies) is needed. The gene discussed is GSTM1; the disease is Iron deficiency anemia.